Market Entry And Exit By Biotech And Device Companies Funded By Venture Capital
Lawton R. Burns(University of Arizona), Charles A. Robinson(Center for Global Development), Michael Housman
Cited by 17
Related Papers
Sjögren's syndrome. Proposed criteria for classification
|Arthritis & Rheumatism|1986|685
Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients
|The Lancet|1997|501
Oral Ganciclovir for Patients with Cytomegalovirus Retinitis Treated with a Ganciclovir Implant
|New England Journal of Medicine|1999|485
A Controlled Trial of Valganciclovir as Induction Therapy for Cytomegalovirus Retinitis
|New England Journal of Medicine|2002|394
Valganciclovir Results in Improved Oral Absorption of Ganciclovir in Liver Transplant Recipients
|Antimicrobial Agents and Chemotherapy|2000|363